Hib (Hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): Hib (Hib3) immunization coverage among 1-year-olds (%) was 81.0% in 2025. ◆ Volatile
Hib (Hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hib (hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region) is 81.0%, measured in 2025.
The figure is up 1.2% on the previous year and up 2.5% over ten years.
Over the whole period, hib (hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region) peaked at 84.0% in 2019 and was at its lowest, 1.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Hib (Hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 4.0% | +300.0% |
| 2002 | 8.0% | +100.0% |
| 2003 | 9.0% | +12.5% |
| 2004 | 9.0% | +0.0% |
| 2005 | 11.0% | +22.2% |
| 2006 | 12.0% | +9.1% |
| 2007 | 17.0% | +41.7% |
| 2008 | 25.0% | +47.1% |
| 2009 | 46.0% | +84.0% |
| 2010 | 46.0% | +0.0% |
| 2011 | 51.0% | +10.9% |
| 2012 | 53.0% | +3.9% |
| 2013 | 56.0% | +5.7% |
| 2014 | 71.0% | +26.8% |
| 2015 | 79.0% | +11.3% |
| 2016 | 81.0% | +2.5% |
| 2017 | 82.0% | +1.2% |
| 2018 | 83.0% | +1.2% |
| 2019 | 84.0% | +1.2% |
| 2020 | 81.0% | -3.6% |
| 2021 | 81.0% | +0.0% |
| 2022 | 84.0% | +3.7% |
| 2023 | 80.0% | -4.8% |
| 2024 | 80.0% | +0.0% |
| 2025 | 81.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.2% | 1.0% | 46.0% | 10 |
| 2010s | 68.6% | 46.0% | 84.0% | 10 |
| 2020s | 81.2% | 80.0% | 84.0% | 6 |
More health data for Eastern Mediterranean (WHO region)
- Measles - number of reported cases, gaps filled 83,590 (2025)
- Diphtheria - number of reported cases, gaps filled 5,830 (2025)
- Total tetanus - number of reported cases, gaps filled 524 (2025)
- Pertussis - number of reported cases, gaps filled 14,992 (2025)
- Measles - number of reported cases, annual growth rate 6.13 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 140.84 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 11.73 % change on previous year (2025)
- Total tetanus - number of reported cases 524 (2025)
- Diphtheria - number of reported cases 5,830 (2025)
- Pertussis - number of reported cases 14,992 (2025)
Frequently asked questions
- What is hib (hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region)?
- Hib (hib3) immunization coverage among 1-year-olds (%) in Eastern Mediterranean (WHO region) was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hib (hib3) immunization coverage among 1-year-olds (%) recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 84.0% in 2019.
- What is the lowest hib (hib3) immunization coverage among 1-year-olds (%) recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 1.0% in 2000.
- How does Eastern Mediterranean (WHO region) rank for hib (hib3) immunization coverage among 1-year-olds (%)?
- Eastern Mediterranean (WHO region) ranks 6th out of 11 groups with data for 2025.
- Is hib (hib3) immunization coverage among 1-year-olds (%) rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 2.5%. The long-run trend across the full record is volatile.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hib (Hib3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).